- Advertisement -spot_img
Thursday, January 20, 2022

The CDC recommends giving preference to vaccines other than J. & J.

The Centers for Disease Control and Prevention recommended on Thursday that Covid vaccines other than Johnson & Johnson’s vaccine should be preferred after their advisers cited growing evidence that the company’s shots could cause a rare bleeding disorder now associated with dozens of cases and at least nine deaths. in the US last year.

The decision adopted a recommendation from a panel of experts that effectively discouraged vaccine providers and adults from using Johnson & Johnson’s vaccine. New data showed that the risk of blood clotting was higher than previously known. The risk was greatest among women between 30 and 49, estimated at 1 in 100,000 injected at the company.

The Johnson & Johnson vaccine is not being removed from the market. The agency said it will remain an option for people who “can’t or don’t want” to get more popular imagery from Moderna or Pfizer-BioNTech.

This recommendation is the latest setback for a vaccine that has largely fallen out of favor in the United States. The company’s vaccine has fallen short of its initial promises as a traditional, one-off format that could be easily applied in more isolated or rural communities, or among people who are afraid of two doses.

About 16 million people in the United States received the Johnson & Johnson vaccine as a primary immunization, compared with 73 million fully immunized with Moderna vaccine and 114 million with Pfizer-BioNTech vaccines. Among Americans who received booster vaccinations, only 1.6% chose Johnson & Johnson.

This week, the FDA released updated guidance on the risks of bleeding disorders associated with Johnson & Johnson’s vaccine, but reiterated that the benefits outweigh the risks.

Dozens of countries have approved the Johnson & Johnson vaccine and are using it in their immunization campaigns. But while it is still in high demand in some parts of the world, it has lost popularity in many countries due to security concerns and its relative low effectiveness against Covid.

Some governments have already begun to impose restrictions on Johnson & Johnson’s vaccinations due to the risk of blood clotting. Finland, Denmark and Slovenia have phased out its use, and several other countries have rated its use lower than Pfizer-BioNTech and Moderna vaccines. Several countries have also recommended that doctors advise women under 50 about the potential risk.

Read Also:  From October, it will be impossible for most Australians to capitulate, but this is mainly because of Canberra's little-known 'homework police'.

The CDC group’s recommendation is at the center of a spike in virus infections caused by the Delta variant of the coronavirus and the latest version of Omicron, which has already become dominant in some countries and is rapidly spreading in the UK and the US.

Several laboratory experiments show that a single dose of Johnson & Johnson’s shot may provide little protection against Omicron contamination. Late last month, the company said it was testing blood samples from clinical trial participants who received the vaccine as an enhancer to see how their vaccine-induced antibodies worked against Omicron.

At a meeting of the Advisory Committee on Immunization Practices on Thursday, CDC officials detailed the clotting syndrome identified in 54 people in the United States who were vaccinated by the end of August. The overall incidence of this disease was 3.8 cases per million people who received the vaccine.

People who received the Johnson & Johnson vaccine several months ago are believed to be at no risk of blood clotting, as diagnosed cases usually show symptoms about nine days after vaccination.

An increased risk of illness has also been associated with the AstraZeneca vaccine, which is not licensed in the US. It was not associated with Moderna or Pfizer vaccines.

A growing body of evidence shows that a single dose of Johnson & Johnson vaccine provides far less protection against infection than other vaccines. Federal health authorities in October authorized a booster shot for people who had received a single shot of the company’s vaccine at least two months earlier. They allowed for a mix-and-match approach, allowing people to get a second shot, but Pfizer or Moderna vaccines.

World Nation News Deskhttps://www.worldnationnews.com
World Nation News is a digital news portal website. Which provides important and latest breaking news updates to our audience in an effective and efficient ways, like world’s top stories, entertainment, sports, technology and much more news.
Latest news
Related news
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here